Aap Implantate AG (ETR:AAQ) | Finanzwire

Basculer en Français

9784	Companies
195985	Keywords
127037	Articles
104223	Press releases

Home
Companies
Aap Implantate AG

BRIEF

published on 04/22/2024 at 07:35, 1 year 9 months ago

Aap Implantate AG Reports 5.6% Sales Growth in Q1 2024

Aap Implantate AG Financial Growth Q1 2024 Sales Antibacterial Implant Technology MDR Authorization
PRESS RELEASE

published on 04/22/2024 at 07:30, 1 year 9 months ago

aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
aap Implantate AG reports 5.6% sales growth in Q1 2024, positive developments across all regions & progress in human clinical trial of antibacterial implant technology

Sales Growth Clinical Trial Aap Implantate AG Q1 2024 Antibacterial Technology
BRIEF

published on 04/19/2024 at 07:35, 1 year 9 months ago

Aap Implantate AG Announces Successful 10% Capital Increase

Medical Technology Capital Increase Aap Implantate AG Financial Strategy Antibacterial Implant Technology
PRESS RELEASE

published on 04/19/2024 at 07:30, 1 year 9 months ago

aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
aap Implantate AG successfully completes 10% capital increase at EUR 1.10, raising EUR 986,311.70 for human clinical trial of antibacterial implant technology

Capital Increase Authorized Capital Clinical Trial Aap Implantate AG Antibacterial Implant Technology
BRIEF

published on 04/17/2024 at 19:02, 1 year 9 months ago

Aap Implantate AG Delays 2023 Financial Report Release Due to Staffing Issues

Annual General Meeting Aap Implantate AG Financial Statements Delay Staff Shortages Auditing Changes
PRESS RELEASE

published on 04/17/2024 at 18:57, 1 year 9 months ago

EQS-Adhoc: aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages
aap Implantate AG postpones the publication of the consolidated financial statements 2023 due to staff shortages. The Annual General Meeting may also be affected by this delay

Consolidated Financial Statements Annual General Meeting Aap Implantate AG Postponement Staff Shortages
BRIEF

published on 04/03/2024 at 17:40, 1 year 9 months ago

Aap Implantate AG Achieves Unanimous Approval for Bond Terms Amendment

Corporate Finance Aap Implantate AG Convertible Bond Bondholders Vote Financial Approval
PRESS RELEASE

published on 04/03/2024 at 17:35, 1 year 9 months ago

aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028
aap Implantate AG receives 100% approval to amend terms of mandatory convertible bond 2023/2028. Bondholders granted early conversion option without lock-up period. Strong support from creditors

Bondholders Amendment Aap Implantate AG Mandatory Convertible Bond Approval
BRIEF

published on 03/18/2024 at 12:40, 1 year 10 months ago

Aap Implantate AG Announces Capital Increase with Exclusion of Subscription Rights

Medical Technology Capital Increase Aap Implantate AG Equity Strengthening Traumatology
PRESS RELEASE

published on 03/18/2024 at 12:35, 1 year 10 months ago

EQS-Adhoc: aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights
aap Implantate AG announces capital increase of EUR 896,647.00 through private placement for strengthening equity base. Share capital to increase to EUR 9,863,121.00 with issue price per share of EUR 1.10

Private Placement Capital Increase Authorized Capital Equity Base Aap Implantate AG

Accesswire

Published on 02/02/2026 at 15:00, 5 hours 6 minutes ago

Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform
Published on 02/02/2026 at 14:30, 5 hours 36 minutes ago

Unusual Machines Promotes Drew Camden to President
Published on 02/02/2026 at 14:30, 5 hours 36 minutes ago

Predictiv AI Provides Pilot Update from Innovate Calgary's Soaring Higher Challenge with Calgary Airports and WestJet
Published on 02/02/2026 at 14:30, 5 hours 36 minutes ago

NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres
Published on 02/02/2026 at 14:00, 6 hours 6 minutes ago

Paymetrex Launches Patent Licensing Program to Monetize Mobile Payments IP Portfolio

View all ACCESSWIRE

EQS Group

Published on 02/02/2026 at 19:57, 9 minutes ago

US federal court grants preliminary injunction allowing Sunrise Wind construction to resume
Published on 02/02/2026 at 19:42, 24 minutes ago

EQS-Adhoc: ProSiebenSat.1 publishes preliminary figures for financial year 2025
Published on 02/02/2026 at 19:05, 1 hour 1 minute ago

Virtual Science AI launches the life science industry's first medical congress AI solution for real-time event conversational intelligence
Published on 02/02/2026 at 18:59, 1 hour 7 minutes ago

EQS-Adhoc: Deutsche Rohstoff AG: Oil and Gas Reserves increase by 46% – NPV of USD 542 million at USD 60 WTI oil price
Published on 02/02/2026 at 18:59, 1 hour 7 minutes ago

EQS-Adhoc: BayWa AG: BayWa AG Executive Board in precautionary talks with financing partners and major shareholders regarding potential adjustments of restructuring concept

Les Echos

Published on 02/02/2026 at 18:23, 1 hour 43 minutes ago

Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:00, 2 hours 6 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 17:35, 2 hours 31 minutes ago

Disclosure of transactions in own shares from January 26 to January 30, 2026
Published on 02/02/2026 at 17:22, 2 hours 44 minutes ago

Statement of transactions in own shares from January 26, 2026 to January 30, 2026
Published on 02/02/2026 at 08:45, 11 hours 21 minutes ago

BAIKOWSKI: Business growth in 2025

View all LES ECHOS COMFI WIRE